Trial Profile
A prospective study in real life setting to investigated the efficacy of bendamustine in patients with Non Hodgkin'S Lymphoma in Tuscany region.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 15 Dec 2015 New trial record